StonvexLoading…
StonvexStonvexStonvexCore line items from SN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.40B | $5.53B | $4.25B | $3.72B |
Operating Income | $920.28M | $644.16M | $373.56M | $321.37M |
Net Income | $701.37M | $438.70M | $167.08M | $232.35M |
EPS (Diluted) | $4.94 | $3.11 | $1.20 | $1.67 |
Total Assets | $5.35B | $4.39B | $3.49B | $3.29B |
Total Liabilities | $2.67B | $2.46B | $2.01B | $1.47B |
Cash & Equivalents | $777.29M | $363.67M | $154.06M | $192.89M |
Free Cash Flow OCF − CapEx | $488.05M | $308.93M | $157.86M | $124.71M |
Shares Outstanding | 141.16M | 140.35M | 139.08M | 138.98M |